Patent ID: 11919960
Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. An antibody or antigen-binding fragment thereof, wherein the antibody or antigen-binding fragment thereof comprises:
a) the amino acid sequence of SEQ ID NO: 3 or SEQ ID NO: 11 as variable heavy chain complementarity determining region 3;
the amino acid sequence of SEQ ID NO: 1 as a variable heavy chain complementarity determining region 1;
the amino acid sequence for SEQ ID NO:2 as a variable heavy chain complementarity determining region 2;
the amino acid sequence of SEQ ID NO: 4 as a variable light chain complementarity determining region 1;
the amino acid sequence of SEQ ID NO: 5 as a variable light chain complementarity determining region 2; and
the amino acid sequence of SEQ ID NO:6 as variable light chain complementarity determining region 3, or,
wherein the antibody or antigen-binding fragment thereof comprises:
b) the amino acid sequence of SEQ ID NO:11 as variable heavy chain complementarity determining region 3;
the amino acid sequence of SEQ ID NO: 9 as a variable heavy chain complementarity determining region 1;
the amino acid sequence for or SEQ ID NO: 10 as a variable heavy chain complementarity determining region 2;
the amino acid sequence of SEQ ID NO: 12 as a variable light chain complementarity determining region 1;
the amino acid sequence of SEQ ID NO: 13 as a variable light chain complementarity determining region 2; and
the amino acid sequence of SEQ ID NO:14 as variable light chain complementarity determining region 3.